Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$8.77 USD
+0.63 (7.74%)
Updated May 10, 2024 04:00 PM ET
After-Market: $8.78 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.89 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | -19.44% |
ABR | 1.22 |
Earnings ESP
|
22.82% |
---|---|
Current Year | -3.05 |
Next Year | -3.04 |
EPS (TTM) | -2.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 3.09M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 3.09M |
Low Estimate | NA | NA | NA | 3.09M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.89 | -0.79 | -3.05 | -3.04 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | -0.89 | -0.58 | -2.63 | -3.18 |
High Estimate | -0.69 | -0.58 | -2.48 | -2.37 |
Low Estimate | -0.97 | -1.05 | -4.42 | -4.14 |
Year ago EPS | -0.58 | -0.63 | -2.74 | -3.05 |
Year over Year Growth Est. | -53.45% | -25.40% | -11.31% | 0.22% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 3 | 2 |
Up Last 60 Days | 0 | 1 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.89 | -0.79 | -3.05 | -3.04 |
7 Days Ago | -0.89 | -0.79 | -3.05 | -3.04 |
30 Days Ago | -0.95 | -0.89 | -3.42 | -3.36 |
60 Days Ago | -0.75 | -0.82 | -2.98 | -2.88 |
90 Days Ago | -0.75 | -0.82 | -2.98 | -2.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.69 | -0.76 | -2.75 | -2.83 |
Zacks Consensus Estimate | -0.89 | -0.79 | -3.05 | -3.04 |
Earnings ESP | 22.82% | 3.82% | 9.84% | 7.01% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -0.66 | -0.63 | -0.58 | NA |
Estimate | -0.72 | -0.72 | -0.68 | -0.64 | NA |
Difference | -0.14 | 0.06 | 0.05 | 0.06 | 0.01 |
Surprise | -19.44% | 8.33% | 7.35% | 9.38% | 1.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more